🔍

Gem Aromatics Limited (GEMAROMA)

₹148.50 +1.87% last close, 16 Oct

📊 NSE: GEMAROMA 🏢 Specialty Chemicals 📢 Latest filing: 22 Sep 2026 📝 Analysis written: 13 Nov 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Gem Aromatics' revenue was ₹98.8 Cr (+12.8% year on year, -10.5% on the previous quarter), and net profit ₹-7.9 Cr (against a profit a year earlier); the operating margin was 3.3%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹98.8	+12.8%	-10.5%
Operating profit	₹3.3	-77.7%	-79.0%
Net profit	₹-7.9	to loss	to loss
EPS (₹)	-1.56	to loss	to loss
Operating margin	3.3%	—	—

Full quarterly financials → Results calendar →

GEMAROMA delivery percentage

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 59.27% of the GEMAROMA shares traded on NSE were taken to delivery, against the stock's own 20-session average of 57.08%. That is close to its usual level. Turnover was only ₹83 lakh, so a handful of trades can move this figure.

59.27%Delivery, 16 Oct

57.08%Own 20-session average

0.7×Volume vs its average

₹148.50NSE close · +1.87%

Delivery in the last 5 sessions: 65.9% · 54.7% · 54.5% · 60.4% · 59.3%

Delivery across the market →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Gem Aromatics Approves Conversion of Inter-Company Loan into Krystal Ingredients Equity at ₹47,710/Sh

🟡 NEUTRAL ⭐ 4/10

OTHER 📅 22 Sep 2026, 06:06 PM

Gem Aromatics' Executive Committee has approved converting pre-existing inter-company loans extended to its wholly owned subsidiary, Krystal Ingredients Private Limited, into equity shares. The shares will be issued at ₹47,710 per share (₹10 face value plus ₹47,700 premium), with no fresh cash outflow involved. Krystal Ingredients reported FY26 turnover of ₹32.33 Cr (₹3,23,296.64 thousand) and a net worth of ₹59.86 Cr (₹5,98,643.63 thousand). The transaction preserves 100% ownership while strengthening the subsidiary's balance sheet to support business operations and expansion.

Conversion of existing inter-company loan into equity with zero fresh capital infusion
Subsidiary shares to be issued at ₹47,710 per share (face value ₹10 plus ₹47,700 premium)
Krystal Ingredients FY26 turnover stood at ₹32.33 Cr (up from ₹2.90 Cr in FY25)
Krystal Ingredients net worth for FY26 reported at ₹59.86 Cr
Shareholding remains unchanged at 100% wholly owned subsidiary

💡 Track the operational ramp-up and margin delivery from the Dahej multi-purpose facility housed under Krystal Ingredients over upcoming quarterly reports.

Q1 FY27 Concall: Cons Revenue ₹99 Cr, Net Loss ₹7.9 Cr as ₹265 Cr Dahej Capex Capitalized

🟡 NEUTRAL ⭐ 5/10

EARNINGS 📅 20 Aug 2026, 12:14 PM

Gem Aromatics reported Q1 FY27 consolidated revenue of ₹99 Cr (up 12.5% YoY from ₹88 Cr), but posted a consolidated net loss of ₹7.9 Cr due to ₹9.1 Cr of depreciation following the capitalization of its Dahej facility. The company has incurred ~₹265 Cr out of its planned ~₹270 Cr capex (representing ~75% of TTM revenue). EBITDA margin stood at 3.3% on a consolidated basis, impacted by operating drag at the new plant and raw material disruptions in the clove vertical caused by Madagascar floods. Management expects commercial supplies from new verticals (cooling agents, Safranal, and phenol derivatives) to scale meaningfully from Q3 and Q4 FY27.

Consolidated revenue stood at ₹99 Cr in Q1 FY27 vs ₹88 Cr in Q1 FY26; standalone revenue reached ₹83 Cr.
Reported consolidated net loss of ₹7.9 Cr, weighed down by ₹9.1 Cr depreciation post capitalization of the Dahej plant.
Total capex of ~₹270 Cr is nearly complete, with ~₹265 Cr already incurred and substantially capitalized.
Commercial production for Safranal and cooling agents (Gemcool 3, 5, 23) has commenced, with meaningful revenue guided from Q3 FY27.
Approved incorporation of a Brazil subsidiary to expand distribution across Latin America.

💡 Track the quarterly commercialization progress and capacity utilization of the Dahej facility over Q2–Q4 FY27, along with gross margin recovery in the clove vertical.

Gem Aromatics Concludes 29th AGM; Shareholders Approve All 13 Resolutions

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 19 Aug 2026, 09:05 PM

Gem Aromatics Limited held its 29th Annual General Meeting (AGM) on August 19, 2026, with 62 members in attendance (7 promoter group, 55 public). Shareholders considered and passed all 13 resolutions with requisite majority, including the adoption of FY26 standalone and consolidated financial statements. Key approvals included the appointment and remuneration of Whole-Time Director Dinesh Vasu Thekkepanakkal and Independent Director Nandan Narula, alongside reappointments and executive remuneration for key managerial personnel.

29th AGM conducted successfully on August 19, 2026, via Video Conferencing.
A total of 62 members attended the meeting, comprising 7 from the promoter group and 55 public shareholders.
Shareholders approved all 13 ordinary and special resolutions set out in the AGM notice.
Approved director appointments including Dinesh Vasu Thekkepanakkal as Whole-Time Director and Nandan Narula as Independent Director.

💡 Track the detailed voting breakdown (scrutinizer's report) on exchange filings, and monitor upcoming Q2 FY27 financial performance and Dahej facility ramp-up progress.

Gem Aromatics Concludes 29th AGM; 13 Resolutions Transacted Across Governance & Remuneration

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 19 Aug 2026, 08:41 PM

Gem Aromatics Limited conducted its 29th Annual General Meeting (AGM) on August 19, 2026, with a total of 62 members attending via video conferencing (7 promoter, 55 public). Shareholders considered 13 agenda items covering the adoption of FY26 audited standalone and consolidated financial statements, statutory auditor ratifications, and director re-appointments. Special resolutions transacted included the appointment of Mr. Dinesh Vasu Thekkepanakkal as Whole-Time Director, Mr. Nandan Narula as Independent Director for 5 years effective May 21, 2026, and executive remuneration packages.

29th AGM conducted on August 19, 2026, with 62 members present (7 promoter group and 55 public)
A total of 13 agenda resolutions were transacted, covering ordinary business and special governance items
Appointed Mr. Dinesh Vasu Thekkepanakkal as Whole-Time Director and Mr. Nandan Narula as Independent Director for 5 years effective May 21, 2026
Auditor and Secretarial Auditor reports for FY26 contained zero qualifications, adverse remarks, or reservations

💡 Track the upcoming disclosure of formal voting results (scrutinizer report) and monitor Q2 FY27 performance for operational ramp-up at the Dahej facility.

Gem Aromatics Releases Audio Recording of Q1 FY27 Earnings Conference Call

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 14 Aug 2026, 06:40 PM

Gem Aromatics Limited has informed the stock exchanges regarding the availability of the audio recording for its Q1 FY27 investor and analyst conference call. The call was conducted virtually on Friday, August 14, 2026, at 4:00 p.m. IST. The recording has been made accessible to the public via a direct link on the company's official website. This is a standard post-earnings regulatory disclosure under SEBI LODR Regulation 30.

Audio recording released for the Q1 FY27 earnings conference call
Earnings call conducted virtually on August 14, 2026, at 4:00 p.m. IST
Recording made accessible via the company's dedicated investor portal

💡 Investors tracking the company should review the con-call audio or await the written transcript to assess management commentary on product mix shifts and Dahej facility utilization.

Rs 265 Cr Dahej Capex Capitalized; Q1FY27 Revenue Up 13% but PAT Turns Negative

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 13 Aug 2026, 07:20 PM

Gem Aromatics reported a 13% YoY increase in consolidated revenue to Rs 98.9 Cr for Q1FY27, but posted a net loss of Rs 7.9 Cr compared to a profit of Rs 8.0 Cr in the previous year. The bottom line was severely impacted by a 405% surge in depreciation (Rs 9.1 Cr) following the capitalization of the Rs 265 Cr Dahej facility. Gross margins contracted significantly to 16.7% from 29.5% due to higher raw material costs and a seasonally softer product mix. The company is transitioning its portfolio toward higher-value specialty molecules, with commercial production of phenol derivatives expected in Q3FY27.

Consolidated revenue grew 13% YoY to Rs 98.9 Cr in Q1FY27, despite a seasonally softer quarter.
Capitalized ~Rs 265 Cr for the Dahej facility, representing approximately 29% of the current market capitalization.
Reported a consolidated net loss of Rs 7.9 Cr, primarily due to depreciation jumping to Rs 9.1 Cr from Rs 1.8 Cr YoY.
Gross margins compressed by 1,282 bps YoY to 16.7% due to product mix and higher raw material costs.
Commercial production for Phenol derivatives is targeted for Q3FY27, with revenue contribution expected from Q4FY27.

💡 Monitor the utilization ramp-up at the Dahej facility and the margin trajectory as the product mix shifts toward specialty chemicals; watch for the start of revenue from cooling agents and phenol derivatives in H2FY27.

Gem Aromatics Q1 FY27: Revenue Up 12.8% YoY to ‡98.9 Cr; PAT Turns to ‡7.9 Cr Loss

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 13 Aug 2026, 07:08 PM

Gem Aromatics reported a 12.8% YoY increase in consolidated revenue to ‡98.9 cr for Q1 FY27, but faced a sharp decline in profitability. The company posted a consolidated net loss of ‡7.9 cr, down from a profit of ‡8.0 cr in Q1 FY26, primarily due to a 1,282 bps contraction in gross margins. This margin pressure was driven by higher raw material costs (clove floods in Madagascar) and a ‡9.1 cr depreciation charge following the capitalization of the ‡265 cr Dahej facility. Management expects revenue from new high-margin verticals like Phenol derivatives to begin contributing meaningfully from Q4 FY27.

Consolidated EBITDA crashed 77.7% YoY to ‡3.3 cr, with margins shrinking from 17.0% to 3.3%.
Depreciation expense surged to ‡9.1 cr following the capitalization of the ‡265 cr Dahej facility.
Gross margins compressed by 1,282 bps YoY to 16.7% due to raw material volatility and product mix.
Secured initial orders for cooling agents (GEM Cool series) with commercial supplies scaling in Q3 FY27.
Approved incorporation of a new wholly-owned subsidiary in Brazil to target the Latin American market.

💡 Watch for the utilization levels of the Dahej facility over the next two quarters; the key trigger will be the commencement of commercial Phenol derivative production in Q3/Q4 FY27 to offset high fixed costs.

Gem Aromatics Q1 Standalone PAT Up 11% to ₹7.25 Cr; Consolidated Swings to ₹7.87 Cr Loss

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 13 Aug 2026, 05:54 PM

Gem Aromatics reported a mixed Q1 FY27 performance with standalone revenue growing 8.6% YoY to ₹82.99 cr and standalone PAT rising 11.2% to ₹7.25 cr. However, the consolidated results show a significant net loss of ₹7.87 cr, compared to a profit of ₹7.98 cr in the same quarter last year, indicating a heavy drag from subsidiaries. The company also transitioned its inventory valuation method from Weighted Average to FIFO effective April 1, 2026, which was applied prospectively due to the complexity of its manufacturing processes.

Standalone revenue from operations increased to ₹82.99 cr from ₹76.40 cr in Q1 FY26.
Consolidated net loss of ₹7.87 cr recorded for the quarter vs a profit of ₹7.98 cr YoY.
Inventory valuation policy changed to FIFO from Weighted Average Cost starting April 1, 2026.
Consolidated EPS dropped to ₹(1.56) from ₹1.70 in the previous year's corresponding quarter.
Standalone finance costs decreased significantly to ₹1.33 cr from ₹2.93 cr YoY.

💡 Investors should monitor the operational ramp-up and path to profitability for the Dahej facility (Krystal Ingredients), which appears to be the primary driver of the consolidated losses.

Gem Aromatics Schedules Q1FY27 Earnings Call for August 14, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 11 Aug 2026, 05:58 PM

Gem Aromatics has scheduled an analyst and investor conference call on August 14, 2026, at 4:00 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2026. This follows a challenging FY26 where the company reported a thin net profit of ₹0.41 cr on revenue of ₹256.06 cr. Investors will be looking for updates on the Dahej multi-purpose facility ramp-up, which is central to the company's target of reaching ₹1,050-1,100 cr in revenue by FY28. The call will also likely address the impact of 50% US tariffs on Indian imports, affecting 30% of the company's revenue.

Earnings conference call scheduled for August 14, 2026, at 4:00 PM IST
Discussion to focus on Q1FY27 unaudited financial results
Company aims for a revenue target of ₹1,050-1,100 cr by FY28, a significant jump from FY26 revenue of ₹256.06 cr
Management to address the ramp-up of the Dahej facility with a capacity of 10,829 units
US market exposure stands at 30% of total revenue, currently impacted by high tariffs

💡 Monitor the post-call transcript or recording for management's guidance on EBITDA margins (targeted at 16-18%) and the timeline for launching new Phenol derivatives to offset recent revenue declines.

Gem Aromatics Schedules 29th AGM for August 19, 2026; Annual Report Released

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Jul 2026, 06:50 PM

Gem Aromatics has announced its 29th Annual General Meeting (AGM) for August 19, 2026, and has dispatched the FY2025-26 Annual Report weblinks to shareholders. This follows a period of financial pressure, with the company reporting a net loss of ‡4.99 cr in the Dec 2025 quarter. Investors should focus on the Annual Report for updates on the Dahej facility ramp-up, which is central to the company's ‡1,050-1,100 cr revenue target for FY28. The cut-off date for shareholder eligibility for this dispatch was July 24, 2026.

29th Annual General Meeting scheduled for August 19, 2026, at 11:30 AM via Video Conferencing.
Cut-off date for identifying shareholders for dispatch was July 24, 2026.
Company maintains a long-term revenue target of ‡1,050-1,100 Cr by FY28.
New Greenfield plant at Dahej has a capacity of 10,829 units for specialty aroma chemicals.
Dec 2025 quarter recorded a net loss of ‡4.99 cr against revenue of ‡78.90 cr.

💡 Review the Annual Report specifically for management's strategy to mitigate the 50% US tariff impact and the timeline for shifting the product mix away from Mint (currently 70% of revenue).

Gem Aromatics to hold 29th AGM on August 19, 2026; proposes new Whole-Time Director

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Jul 2026, 01:21 PM

Gem Aromatics has scheduled its 29th Annual General Meeting (AGM) for August 19, 2026, to adopt the FY26 financial statements and ratify board appointments. Key agenda items include the appointment of Mr. Dinesh Vasu Thekkepanakkal as a Whole-Time Director for a five-year term and the re-appointment of promoter-directors. This meeting follows a fiscal year (FY26) where the company reported revenue of ₹256.06 cr but thin net profits of ₹0.41 cr. Investors will look for updates on the company's aggressive target to reach ₹1,050-1,100 cr in revenue by FY28.

29th Annual General Meeting scheduled for August 19, 2026, at 11:30 AM IST via Video Conferencing.
Proposed appointment of Mr. Dinesh Vasu Thekkepanakkal as Whole-Time Director for a 5-year term ending May 2031.
Promoter group (Parekh family) maintains a 57.44% stake in the company as of the notice date.
Adoption of FY26 Audited Financial Statements showing annual revenue of ₹256.06 cr.
Re-appointment of Mrs. Kaksha Vipul Parekh and Mr. Yash Parekh as directors retiring by rotation.

💡 Investors should monitor the AGM for management commentary regarding the ramp-up of the Dahej facility and the strategy to improve margins from the current low levels.

Gem Aromatics Reports Zero Demat/Remat Requests for Quarter Ended June 30, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Jul 2026, 07:15 PM

Gem Aromatics Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate, issued by the Registrar and Share Transfer Agent (RTA), KFin Technologies Limited, confirms that no dematerialization or rematerialization requests were processed during the quarter ended June 30, 2026. This is a standard procedural filing required for all listed companies to maintain regulatory compliance.

Zero (0) Demat or Remat requests were processed during the quarter ended June 30, 2026
Compliance certificate issued by KFin Technologies Limited on July 06, 2026
Filing submitted to BSE and NSE on July 10, 2026
Covers the reporting period from April 1, 2026, to June 30, 2026

💡 No action is required as this is a routine administrative filing. Investors should monitor the company's upcoming quarterly financial results for operational performance updates.

Gem Aromatics to Close Trading Window from July 1, 2026 for Q1 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Jun 2026, 03:17 PM

Gem Aromatics Limited has announced the closure of its trading window starting July 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is a standard procedure preceding the announcement of the company's unaudited financial results for the quarter ending June 30, 2026. The restriction applies to all designated persons and their immediate relatives and will remain in effect until 48 hours after the results are declared. The company will announce the specific date for the board meeting to approve these results in a separate filing.

Trading window closure effective from Wednesday, July 1, 2026.
Closure is related to the unaudited financial results for the quarter ending June 30, 2026.
Trading restriction applies to all Designated Persons and their immediate relatives.
Window will reopen 48 hours after the financial results are officially disclosed to the exchanges.

💡 This is a routine regulatory announcement with no direct impact on stock fundamentals. Investors should wait for the announcement of the board meeting date to track the company's Q1 financial performance.

Gem Aromatics to Expand into Brazil with ₹17 Cr Investment; Appoints New Auditors

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 23 Jun 2026, 05:54 PM

Gem Aromatics Limited has approved the incorporation of a wholly-owned subsidiary in Brazil to distribute essential oils and specialty chemicals. The company plans to invest up to ₹2 crore in equity and provide a Standby Letter of Credit (SBLC) of up to ₹15 crore for this international venture. Additionally, the board has appointed M/s. N. L. Bhatia & Associates as Secretarial Auditors for a five-year term and re-appointed M/s. RANK & Associates as Internal Auditors. This expansion signals a strategic push into the South American market to support its global distribution network.

Approved the incorporation of a Wholly Owned Subsidiary in Brazil for the distribution of essential and specialty chemicals.
Total financial commitment for the Brazil entity includes ₹2 crore equity investment and ₹15 crore SBLC.
M/s. N. L. Bhatia & Associates appointed as Secretarial Auditors for a 5-year term from FY 2026-27 to FY 2030-31.
M/s. RANK & Associates re-appointed as Internal Auditors for the Financial Year 2026-27.
The new Brazil entity will also handle distribution for the company's material subsidiary, Krystal Ingredients Private Limited.

💡 Investors should view the Brazil expansion as a positive growth indicator for the company's export business. Monitor future updates regarding the subsidiary's operational commencement and its contribution to the consolidated top line.

Gem Aromatics to Expand in Brazil with ₹17 Crore Investment; Appoints New Auditors

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 23 Jun 2026, 05:53 PM

Gem Aromatics Limited has approved the incorporation of a wholly-owned subsidiary in Brazil to distribute essential oils and specialty chemicals. The company plans a total financial commitment of ₹17 crore, comprising ₹2 crore in equity and a ₹15 crore Standby Letter of Credit (SBLC). On the governance front, the board appointed N. L. Bhatia & Associates as Secretarial Auditors for a five-year term and re-appointed RANK & Associates as Internal Auditors for FY 2026-27. This expansion marks a significant step into the South American market for the company and its subsidiary, Krystal Ingredients.

Approved the incorporation of a Wholly Owned Subsidiary (WOS) in Brazil for chemical distribution.
Total investment for Brazil expansion includes ₹2 crore equity and ₹15 crore SBLC in one or more tranches.
M/s. N. L. Bhatia & Associates appointed as Secretarial Auditors for a 5-year term (FY 2026-27 to 2030-31).
M/s. RANK & Associates re-appointed as Internal Auditors for the Financial Year 2026-27.
The Brazil entity will support distribution for both Gem Aromatics and its material subsidiary, Krystal Ingredients Private Limited.

💡 Investors should monitor the progress of the Brazil subsidiary's setup as it could significantly boost export revenues. The long-term appointment of secretarial auditors also indicates a focus on stable corporate governance.

View All GEMAROMA Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Total revenue for Q2 FY26 was INR 89.5 Cr, a decline of 20.2% YoY from INR 112.2 Cr. H1 FY26 revenue stood at INR 177.2 Cr, down 13.5% YoY. The Mint portfolio, which accounted for 70% of FY25 revenue, saw significant volume contraction due to external headwinds, while Phenol derivatives and other natural/synthetic products remained healthy but lacked the scale to offset the Mint decline.

Geographic Revenue Split

The USA is a critical market, contributing 30% of total revenue in FY25. The company serves a global base of 269+ customers across 18 countries, including major flavor and fragrance houses and FMCG companies.

Profitability Margins

Gross Profit Margin for Q2 FY26 was 14.0%, a sharp decline of 805 bps YoY from 22.1%. PAT Margin for Q2 FY26 turned negative at -2.9% (INR 2.6 Cr loss) compared to 8.7% (INR 9.7 Cr profit) in Q2 FY25. H1 FY26 PAT margin was 3.1% (INR 5.4 Cr) versus 8.9% (INR 18.3 Cr) YoY.

EBITDA Margin

EBITDA Margin for Q2 FY26 crashed to 3.4% (INR 3.0 Cr) from 13.7% (INR 15.3 Cr) in Q2 FY25, a drop of 1,027 bps. H1 FY26 EBITDA margin was 10.1% (INR 17.9 Cr) compared to 14.4% (INR 29.6 Cr) YoY, impacted by high raw material costs and lower realizations in the Mint segment.

Capital Expenditure

The company completed capitalization of major assets at its subsidiary, Krystal Ingredients, in H1 FY26. The Net Block increased to INR 206.2 Cr as of September 30, 2025, from INR 43.4 Cr in March 2025. Capital Work-in-Progress (CWIP) stood at INR 25.1 Cr.

Credit Rating & Borrowing

The company utilized IPO proceeds to repay INR 140 Cr of debt, including INR 97.4 Cr of long-term debt for Krystal Ingredients and INR 42.6 Cr of working capital debt. This improved the Net Debt to Equity ratio from 0.8x to 0.3x. Finance costs for H1 FY26 were INR 7.0 Cr, up from INR 2.4 Cr YoY.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Natural Mint Oil, Synthetic Mint Oil, Clove Oil, and Phenol. Mint-based materials represent the largest cost component, historically supporting 70% of revenue.

Import Sources

Not explicitly disclosed, though the company operates facilities in Silvassa, Badaun (U.P.), and a new Greenfield project in Dahej (Gujarat).

Capacity Expansion

The company has established a new Greenfield multi-purpose plant at Dahej under Krystal Ingredients with a capacity of 10,829 units. This facility is designed to manufacture Phenol derivatives like MEHQ and other specialty aroma chemicals.

Raw Material Costs

Cost of Goods Sold (COGS) for H1 FY26 was INR 138.7 Cr, representing 78.3% of revenue. Profitability was pressured by high raw material costs in the Mint segment and inventory adjustments during Q2 FY26.

Manufacturing Efficiency

Depreciation increased to INR 4.9 Cr in H1 FY26 from INR 3.5 Cr YoY following the capitalization of the Dahej facility, impacting short-term net profitability.

Logistics & Distribution

Other expenses, including logistics and distribution, rose to INR 14.6 Cr in H1 FY26 from INR 11.6 Cr YoY.

📈 Strategic Growth

Expected Growth Rate

30%

Growth Strategy

The company aims to reach INR 1,050-1,100 Cr in revenue by FY28 with 16-18% EBITDA margins. This will be achieved by ramping up the Dahej multi-purpose facility, shifting the product mix from Mint (70% of revenue) toward higher-margin Phenol derivatives (MEHQ) and specialty Aroma chemicals, and expanding the global customer base beyond the current 269 clients.

Products & Services

Menthol, Mint derivatives, Clove Oil, Clove Oil derivatives, Phenol derivatives (MEHQ), and various Natural and Synthetic Aroma molecules.

Brand Portfolio

GEM Aromatics, Krystal Ingredients (Subsidiary).

New Products/Services

New value-added specialty Aroma products and Phenol derivatives (MEHQ) are being fast-tracked for launch to offset the 20.2% decline in Q2 revenue.

Market Expansion

Targeting new global customers for Menthol and Aroma chemicals as the Dahej production ramps up; currently serving 18 countries.

Strategic Alliances

doTERRA Enterprises, Sàrl is a strategic investor (shareholder) and a key customer, providing value-add to the business through long-standing partnership.

🌍 External Factors

Industry Trends

The industry is shifting toward natural and wellness-focused ingredients. GEM Aromatics is positioning itself as a specialty ingredient company by moving away from commodity mint into integrated chemistry and next-generation aroma molecules.

Competitive Landscape

Faces competition in the Phenol derivative business from existing Indian manufacturers, though the company's multi-purpose plant at Dahej is designed for margin-accretive specialty products.

Competitive Moat

Durable advantages include a 27-year operating history, integrated manufacturing capabilities, a diversified portfolio of 269+ global customers, and a strategic partnership with doTERRA. These are sustainable due to high entry barriers in specialty chemical manufacturing and long-term customer trust.

Macro Economic Sensitivity

Highly sensitive to international trade policies and domestic tax structures, as evidenced by the immediate impact of US tariffs and Indian GST changes.

Consumer Behavior

Shift toward natural ingredients and wellness products is driving demand for the company's natural aroma and essential oil portfolio.

Geopolitical Risks

Significant exposure to US-India trade relations; a 50% tariff on Indian imports imposed in August 2025 led to a 20.2% YoY revenue drop in Q2 FY26.

⚖️ Regulatory & Governance

Industry Regulations

Impacted by GST revisions effective September 2, 2025, which set Natural Mint Oil at 5% and Synthetic Mint Oil at 18% (previously a uniform 12%), disrupting domestic procurement and blending models.

Taxation Policy Impact

Effective tax rate for H1 FY26 was approximately 35% (INR 2.9 Cr tax on INR 8.3 Cr PBT).

⚠️ Risk Analysis

Key Uncertainties

Uncertainty regarding future US trade policies and the duration of the 50% tariff impact could continue to suppress 30% of the company's revenue stream.